Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.
一项 Ib 期研究,旨在通过新辅助西妥昔单抗和 TLR8 刺激来调节头颈癌的免疫生物标志物,以克服抑制性髓系信号
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-0357
Shayan Gulidanna, Kansy Benjamin A, Gibson Sandra P, Srivastava Raghvendra M, Bryan James Kyle, Bauman Julie E, Ohr James, Kim Seungwon, Duvvuri Umamaheswar, Clump David A, Heron Dwight E, Johnson Jonas T, Hershberg Robert M, Ferris Robert L